Medicon Valley Alliance is hosting a digital meeting focusing on identifying and attracting funding for companies in the early stages of development. Attracting funds for early stage lifescience companies is challenging, however necessary, to ensure further development and growth. Funding can come from many different sources; public soft money, business angels, specialized VCs and through IPOs. This webinar will highlight some aspects of allocating funding and give some advice on how to focus on value creation in early stages as well as some concrete examples of funds available in Medicon Valley. In the meeting we will get a fresh update on the current investment climate in the region from the Scandinavian Investor Climate report by NY consulting, as well as meeting some of the organisations supporting early stage companies financially.
|Date:||8th of April, 2021|
|Host:||Medicon Valley Alliance|
|Venue:||Online – https://zoom.us/j/91686323762|
|14.50-15.00||Online platform open for registered participants|
|15.00-15.10||Welcome Petter Hartman, CEO, Medicon Valley Alliance|
|15.10-15.25||Current investment climate in Medicon Valley – presentation of Scandinavian Investor Climate report Johan Ny, CEO, NY Consulting|
|15.25-15.40||Value creation in early stage LifeScience companies Saurabh Mishra, Managing Partner, Farmantra|
|15.40-15.55||Almi Invest – Sweden’s most active start-up investor Anna Gisselsson, Investment Manager, Almi Invest Syd|
|15.55-16.10||Identifying, building and investing in sustainable startups Camilla Petrycer Hansen, Principal, Novo Seeds|
|16.10-16.30||Discussion and Q&A|
Deadline for registration is 6th of April.